Latin America Plasmid Dna Manufacturing Market Size & Outlook
Latin America plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
Latin America plasmid dna manufacturing market highlights
- The Latin America plasmid dna manufacturing market generated a revenue of USD 111.4 million in 2024.
- The market is expected to grow at a CAGR of 19% from 2025 to 2030.
- In terms of segment, gmp grade was the largest revenue generating grade in 2024.
- GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 111.4 million |
| Market revenue in 2030 | USD 310.4 million |
| Growth rate | 19% (CAGR from 2025 to 2030) |
| Largest segment | Gmp grade |
| Fastest growing segment | GMP Grade |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | R&D Grade, GMP Grade |
| Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
Other key industry trends
- In terms of revenue, Latin America region accounted for 5.2% of the global plasmid dna manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,484.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Manufacturing Market Scope
Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 101.17% in 2024. Horizon Databook has segmented the Latin America plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
The Latin American region is witnessing growing awareness about advanced medical therapies and vaccines. Several review articles are being published, wherein scientists from Mexico, Uruguay, Brazil, Chile, and Argentina are sharing their views on cell and gene therapy research in each of their countries.
Key initiatives adopted in these countries for the promotion of cell therapy research are also illustrated in these articles. This, in turn, is expected to spur the development as well as adoption of advanced therapeutics and plasmid DNA-based end products in this region in the near future.
Furthermore, effective regulatory structure in Colombia pertaining to gene therapy trials is expected to boost the plasmid manufacturing process in the country. However, in Mexico, gene therapy development is restricted by intellectual property and regulatory challenges, which has hampered revenue generation in the overall LATAM market.
Reasons to subscribe to Latin America plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America plasmid dna manufacturing market databook
-
Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America plasmid dna manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America plasmid dna manufacturing market size, by country, 2018-2030 (US$M)
Latin America Plasmid DNA Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
